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Spin trapping of the free radicals formed from the interaction between adriamycin and red blood cells 
resulted in the formation of a hydroxyl spin adduct. The formation of hydroxyl radicah was found to be 
inhibited by mannitol. Hemoglobin was found not to be obligatory for the formation of hydroxyl radicals 
which probably result from the reduction of hydrogen peroxide by adriamycin semiquinone. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The anticancer activity and cardiotoxicity of 
adriamycin (doxorubicin) is believed to occur via a 
free radical mechanism [1,2]. Adriamycin semi- 
quinone radicals are among the metabolites form- 
ed following interaction between adriamycin and 
microsomes derived from heart, liver, spleen, 
L1210 and V388 murine leukaemias and intact 
Ehrlich ascites tumor cells [3]. Subsequent autox- 
idation causes the catalytic production of oxygen- 
centred radicals [2]. Recently adriamycin semi- 
quinone, generated by the reduction of adriamycin 
by superoxide radicals formed from the reaction of 
xanthine oxidase with xanthine, in combination 
with hydrogen peroxide has been shown to 
generate hydroxyl radicals [4]. However, despite 
suggestive vidence using isolated microsomes and 
enzyme systems, the definite generation of inactive 
oxygen species in intact cells by adriamycin has not 
yet been demonstrated. Here, we present for the 
first time direct evidence for the generation of 
hydroxyl radicals by adriamycin in intact red blood 
cells using the electron paramagnetic resonance 
(EPR) technique of spin trapping. 
Adriamycin was obtained from Sigma (Dorset). 
The spin trap, 5,5-dimethyl-1-pyrroline-N-oxide 
(DMPO), was prepared and purified as in [S]. All 
other reagents were of the highest grade available. 
Red blood cells were obtained from whole human 
blood after centrifugation to remove plasma and 
white cells. Sedimented erythrocytes were washed 
4-times with isotonic saline. A 10% haematocrit 
solution of the washed cells was prepared in Krebs- 
Ringer-phosphate buffer, pH 7.4. Erythrocytes 
were carbon-monoxylated by slow purging with 
carbon monoxide. Electron paramagnetic reson- 
ance (EPR) spectra were recorded on a Varian 
E-104X band spectrometer with an E900-3 data 
acquisition system. EPR spectra were recorded 
with a field set at 3385 G, modulation frequency 
100 kHz, modulation amplitude 1 .O G, micro- 
wave power 10 mW and microwave frequency 
9.0478 kHz. Computer averaging of 16 scans from 
t = 0.5-1.5 min gave spectra whose intensities 
represent an estimate of the spin adduct concentra- 
tions. Spin adduct concentrations were Galculated 
from a calibrated double integral. 
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3. RESULTS AND DISCUSSION 
Adriamycin increases oxygen consumption in 
erythrocyte, resulting in hydrogen peroxide pro- 
duction. This is coupled with an increase in hexose 
monophosphate shunt activity [6]. Adriamycin 
stimulation of oxygen uptake is probably linked to 
the production of oxygen-centred free radicals. 
The EPR spectrum of the spin adduct formed 
following interaction between adriamycin and red 
blood cells is shown in fig.la. The EPR spectrum 
was found to have the following spectral charac- 
teristics: g = 2.0050, aN = aH = 14.9. These have 
been assigned to the hydroxyl spin adduct of 
DMPO, 5,5-dimethyl-2-hydroxy-pyrrolidino- l- 
oxyl (DMPO-OH) [7]. The supernatant obtained 
after centrifugation of adriamycin-treated erythro- 
cytes gave no spin adduct spectrum (fig. lb) in- 
dicating that the production of DMPO-OH from 
adriamycin-treated erythrocytes occurs within the 
cell. Adriamycin treatment of carbonmonoxy 
hemoglobin-containing erythrocytes, was also 
found to produce DMPO-OH (fig.Ic). The 
amount of DMPO-OH produced is, however, 
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Fig.1. Spin trapping of the free radicals formed in the 
presence of 100 mM DMPO from 1% red blood cells in 
Krebs-Ringer-Phosphate buffer (pH 7.4) containing 
1 mM DETAPAC after: (a) treatment with 1 mM 
adriamycin; (b) supernatant of (a) after 15 min 
incubation; (c) as in (a) but using carbon-monoxylated 
red blood cells. 
about 50% less than that produced from normal 
erythrocytes. This suggests that oxyhemoglobin is 
involved in DMPO-OH production but that its in- 
volvement may not be obligatory. Oxyhemoglobin 
is considered to be the site of activation of many 
haemolytic drugs inside the erythrocyte [8]. 
However, no detectable spin adduct was observed 
from a solution of 1OpM oxyhemoglobin treated 
with adriamycin or from adriamycin alone. In [9] 
it was postulated that the direct reaction of adri- 
amycin with oxyhemoglobin results in semiqui- 
none formation. 
The effect of various concentrations of mannitol 
on the time course of DMPO-OH production from 
adriamycin-treated erythrocytes is shown in fig.2. 
The progressive decrease in DMPO-OH produc- 
tion with increasing mannitol concentration clearly 
demonstrates that the spin adduct is being formed 
from hydroxyl radicals. Some doubts have been 
expressed in the literature about the true identity of 
the hydroxyl spin adduct of DMPO [lo]. In [9] it 
was postulated that thei formationj of a ‘hydroxyl 
like’ radical from the reaction between adriamycin 
and hemoglobin was also postulated. However, we 
find no evidence of the formation of any other 
radical besides the hydroxyl radical. 
The mechanism of formation of hydroxyl 
radicals by adriamycin is still not clear. In red 
blood cells adriamycin has been shown to stimulate 
the hexose monophosphate shunt and glutathione 
Reactlon Time (mans) 
Fig.2. Effect of various concentrations of mannitol on 
DMPO-OH production from 1 mM adriamycin-treated 
1% red blood cells in Krebs-Ringer-Phosphate buffer 
(pH 7.4) containing 1 mM DETAPAC. (a) Control; (b) 
10 mM; (c) 25 mM; (d) 50 mM. 
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oxidation. Stimulation of the hexose monophos- 
phate shunt is probably occurring because of the 
oxidation of NADPH by adriamycin, resulting in 
the formation of hydrogen peroxide and adri- 
amycin semiquinone radicals. These would be 
unstable to detect [ 111. The production of Hz02 
could be the main cause of glutathione oxidation 
through increased glutathione peroxidase activity. 
Adriamycin semiquinone can also reduce HzOz, 
resulting in the formation of hydroxyl radicals. 
Semiquinones have recently been shown to reduce 
Hz02 to form hydroxyl radicals [12]. We have 
recently demonstrated the formation of hydroxyl 
radicals in red blood cells by the antimalarial drug, 
primaquine, and proposed a mechanism involving 
oxidations of NADPH leading to the formation of 
Hz02 and the primaquine semiquinone which can 
then generate hydroxyl radicals from hydrogen 
peroxide [13]. It appears that in red blood cells 
adriamycin is acting by a similar mechanism. 
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